Skip to main content
Cesar Castro, MD, Oncology, Boston, MA, Massachusetts General Hospital

CesarMartinCastroMDMMSc

Oncology Boston, MA

Gynecologic Cancer

Associate Professor of Medicine at Harvard Medical School

Dr. Castro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Castro's full profile

Already have an account?

Education & Training

  • Harvard Medical School
    Harvard Medical SchoolMMSc, Clinical Investigation, 2009 - 2011
  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2008 - 2011
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 2005 - 2008
  • University of California (San Francisco)
    University of California (San Francisco)Internship, Internal Medicine, 2005 - 2006
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 2005

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2007 - Present
  • NH State Medical License
    NH State Medical License 2013 - 2025
  • MA State Medical License
    MA State Medical License 2008 - 2025
  • American Board of Internal Medicine Medical Oncology
  • American Board of Internal MedicineOncology

Publications & Presentations

PubMed

Journal Articles

  • Phase Ib Study of Mirvetuximab Soravtansine, a Folate Receptor Alpha (FRα)-Targeting Antibody-Drug Conjugate (ADC), in Combination with Bevacizumab in Patients with Pl...  
    David M O'Malley, Ursula A Matulonis, Michael J Birrer, Cesar M Castro, Lainie P Martin, Kathleen N Moore, Gynecologic Oncology

Press Mentions

  • Novel Saliva Assay by Accure Health Tracks COVID-19 Vaccine Response in Proof-of-Concept Study
    Novel Saliva Assay by Accure Health Tracks COVID-19 Vaccine Response in Proof-of-Concept StudyJuly 15th, 2021
  • New Test Can Pinpoint Which Pancreatic Cysts Might Turn Cancerous
    New Test Can Pinpoint Which Pancreatic Cysts Might Turn CancerousJuly 18th, 2019
  • Snapshot of Science: Genetic Insights into Our Food Choices, New Diagnostic Device for Lymphoma and More
    Snapshot of Science: Genetic Insights into Our Food Choices, New Diagnostic Device for Lymphoma and MoreAugust 21st, 2018
  • Join now to see all

Other Languages

  • Spanish

Hospital Affiliations

Industry Relationships

  • Consultant, WaveGuide Corp.
  • Consultant, N-of-One, Inc.